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Cellular  aspects  of genetic regulation  of immune  responsiveness  in mice for two 
synthetic  polypeptide  immunogens  built  on  multichain  polyproline  have  recently 
been investigated by a limiting dilution analysis of lymphoid cell populations in high 
and low responder mouse strains  (1-3). These studies demonstrated a  direct correla- 
tion between the numbers of immunogen-stimulated antigen-sensitive units detected 
in the spleens  of immunized and unimmunized donors and the genetically determined 
immune response potential of a given mouse strain (1, 2). Furthermore, in the case of 
poly-L-(Phe,  Glu)-poly-L-Pro--poly-L-Lys, denoted  (Phe,  G)-Pro--L,  the  strain-de- 
pendent cell frequency differences  observed in the spleens  were also reflected in the 
bone  marrow,  but  not  in  the  thymus  or  thymus-derived  populations  of  relevant 
immunocytes (3).  This was the case irrespective  of whether  the cellular analysis of 
immune responsiveness was determined for the specificity whose response potential is 
H-2 linked, i.e.  (Phe, G), or for the Pro--L specificity,  whose response potential is not 
linked to the I-I-2 region (3-5). 
As (Phe,  G)-Pro--L contains two immunopotent regions which elicit antibodies of 
distinct  specificities  and  the  immune  response  potentials  of  these  two  regions  are 
controlled by separate  genes  (5),  it could be argued that  cellular studies using this 
polypeptide  might represent  a  more  complex situation  than  experiments  in  which 
poly-L-(Tyr,  Glu)-poly-L-Pro--poly-n-Lys, denoted  (T,  G)-Pro--L,  or  poly-L-(Phe, 
Glu)-poly-DL-Ala--poly-L-Lys,  denoted  (Phe,  G)-A--L,  were  investigated.  Further- 
more, the fact that (Phe, G)-A--L is built on a backbone of multichain poly-nl.-alanine, 
whereas the branched polymeric side chains of (T, G)-Pro--L consist of poly-L-proline, 
provides an opportunity for comparing cellular aspects of genetic control of immune 
response as a  function of the chemical structure of the immunogen. The genes con- 
trolling immune responsiveness  to the A--L series  of polypeptides and to the Pro--L 
specificity have been designated Ir-1 and Ir-3, respectively (6). 
The  present  report  describes  experiments  in  which  spleen,  marrow,  and 
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thymus cell-limiting dilutions were compared between high and low respander 
mouse strains for (Phe, G)-A--L. It also extends the previously reported finding 
that  genetic  control  of  immune  responsiveness  to  (T,  G)-Pro-L  could  be 
accounted for by  the  numbers  of  splenic  antigen-sensitive units  stimulated 
in  SJL  and  DBA/1  mice,  to  thymus  and  marrow  cell  dilution  studies. 
For  (Phe,  G)-A--L,  eighteen times  as  many units of  immune response were 
detected  in the  spleens of  immunized DBA/1  high  responder  as  in those  of 
SJL low responder donor mice. Limiting dilution studies using thymocytes and 
marrow  cells  indicated  that  the  genetic  control  of  immune  response  for 
(T,  G)-Pro--L  (which  is  expressed  mainly in  the  formation  of  anti-Pro--L 
antibodies and is not linked to H-2) is reflected only in the number of relevant 
marrow cells stimulated, but apparently not in the thymocyte population. In 
contrast,  for  the  H-2-1inked  (Phe,  G)-A--L response  (essentially only anti- 
[Phe,  G]), both bone marrow and thymus cells were demonstrated to be im- 
portant in expression of the genetic regulation of immune response potential. 
Malerials and Methods 
Mice.--Inbred SJL and DBA/I mice of both sexes, 9-11 wk of age were used as recipients, 
whereas females of the same age were used as donors. Both mouse strains were obtained from 
the Experimental Animal Unit, The Weizmann Institute of Science. 
Immunization and  Assay.--The  immunogens used  were poly-L-(Tyr,Glu)-poly-L-Pro-- 
poly-L-Lys, abbreviated  (T,G)-Pro--L  706, and poly-L-(Phe,Glu)-poly-nL-Ala--poly-L-Lys 
223, abbreviated  (Phe,G)-A--L. The description, synthesis, characterization, and immuno- 
genicity of these pol3l~eptldes  have been reported (4, 5, 7 9). The methods for immunization 
of donor and recipient animals have been published elsewhere (I-3).  The same polypeptides 
used for immunization were also used for assaying the sera of recipients. Sheep erythrocytes 
were formalinized, tanned, and coated either with  (T,G)-Pro--L  or with (Phe, G)-A--L (10), 
and passive microhemagglutinafion tests were performed using twofold dilutions of antlsera 
as described elsewhere (1-3, 11). The hemagglutination assays were performed on the sera from 
individual recipient mice 12-14 days after immunization, at the time of maximum antibody 
titers  (1). 
Irradiation and Cell Transfers.--Recipient mice to be injected with lymphoid cells were 
exposed to 800 R of whole body X-irradiation  (250 kv peak, 15 ma, with 0.5 mm of Cu and 
1.0 mm of A1 added filtration, source-to-target distance 50 cm, and exposure of 60 R/mln) in 
a rotating Lucite chamber. Spleen, bone marrow, and thymus celt suspensions were prepared, 
counted, diluted, and injected as previously described (1-3). 
Experimental Design and Statistical Methods.--The Poisson model was used to describe the 
theoretical probability  that a given inoculum of donor-derived cells would generate  a de- 
tectable titer (at a serum dilution greater than that obtained in irradiated  control mice) of 
anti-(T, G)-Pro--L or anti-(Phe, G)-A--L antibodies in the sera of irradiated  recipients (3). 
Limiting inocula of marrow cells were injected along with an excess of l0  s or 2 X 108 thymo- 
cytes, whereas limiting numbers of thymus cells were mixed with a nonlimiting number of 
2 X 10 ~ marrmv cells before transplantation.  This was done to ensure that the frequencies of 
immune responses obtained would depend mainly on the number of limiting cells injected. 
RESULTS 
Frequency  of Immune  Responses  1o  (Phe,  G)-A--L  in  Syngeneic  Recipients 
Injected with Graded Numbers of Spleen Cells from Immunized or Unimmunized G,  M.  SHEARER,  EDNA  MOZES~  AND  MICHAEL  SELA  1011 
DBA/1  and SJL Donors.--In  repeated experiments a total of 69 DBA/1  and 
106 SJL irradiated recipient mice were injected with graded numbers (5 X  106 -- 
4  X  107) of spleen  cells pooled from immunized  syngeneic donors  and were 
simultaneously immunized with (Phe, G)-A--L. The results presented in Table I 
and Fig. 1 indicate an increase in the fraction of sera positive for (Phe, G)-A--L 
as the number of spleen cells injected was increased. The experimental frequency 
distribution of responses followed the expected Poisson pattern for both mouse 
strains.  The  probability values  (based  on  the  Poisson model  and  maximum 
likelihood method [12]) that 106 spleen cells would contain one unit of immune 
TABLE I 
Percentage of Positive Sera in Irradiated DBA/1 and SJL Recipients 12 Days after Injection 
of (Phe, G)-A--L and Graded Numbers of Syngeneic Spleen Cells  from Immunized Donors 
No. of cells  Percent- 
Mouse strain  transplanted  Fraction of  age of  Probability of positive  Precursor cell 
(X 106)  positive sera*  positive  sera per 10~ cells:~  frequency (X  10-~)~ 
sera 
DBA/1 
% 
0.5  3/14  21 
1  6/14  43  0.63  1/1.6 
2  11/15  73  (0.56-O,71)§  (1/1.4-1/1.8)§ 
4  15/16  93 
8  10/10  100 
SJL  1  o/14  0 
2  2/10  20  0.036  1/28 
4  5/21  24 
8  6/19  32  (0.032-0.041)§  (1/24-1/31)§ 
20  11/22  50 
40  12/20  60 
*  Donor-derived responses showing titers at dilutions greater than 1:4 in recipient sera. 
:~ Probability value estimates were based on the Poisson model. 
§ 95% confidence intervals shown in parentheses. 
response  potential  were  estimated  to  be  0.63  and  0.036  for  high  responder 
DBA/1  and low responder  SJL  spleen  cells,  respectively. The  corresponding 
limiting precursor cell frequencies were estimated at one per 1.6  X  10 ~ and one 
per 28  X  10 ~ spleen cells.  Thus,  a  significant  18-fold difference was observed 
in the relative abilities of spleen cells from immunized SJL and DBA/1 donors 
to generate an immune response to (Phe, G)-A--L. 
Differences  in  the  frequencies  of  splenic  antigen-sensitive  units  associated 
with genetically controlled immune responsiveness have also been reported for 
spleen cells from unimmunized donors using the Pro--L series of immunogens, 
although  these  differences were usually  less pronounced  than  those  observed 
using  immunized  donors  (1,  2).  It was  of  interest  to  establish  whether  the 
differences  observed  between  the  secondary  responses  of  SJL  and  DBA/1 1012  CELL  TYPE  AND  ANTIGEN  STRUCTURE  IN  GENETIC  CON't'ROL 
mice to (Phe,  G)-A--L would also be seen in the primary response.  Groups of 
DBA/1  and  SJL  recipients were  irradiated and  injected with  graded  inocula 
(1  X  106-4  X  107) of  cells harvested  from  pooled  spleens  of  unimmunized 
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FIG. 1.  Percentage of anti  (Phe,G)-A--L-positive sera in SJL  (symbol  O) and DBA/1 
(symbol Q) recipients after irradiation and injection of (Phe, G)-A--L and graded numbers of 
spleen cells from immunized syngeneic donors. 
TABLE II 
Percentage of Positive So'a  in Irradiated DBA/1 and SJL Recipients 14 Days after Injection 
of (Pke, G)-A --L and Graded Numbers of Syngeneic Spleen Cells.from Unlmmunized Donors 
Percent- 
No. of ceils  Fraction of  age of  Probability of positive  Precursor cell  Mouse strain  transplanted  (X lO  ~)  positive sere*  positive  sera per 106 cells:~  frequency (X 10-6):} 
sere* 
% 
DBA/1  1  2/8  25 
2  6/12  50 
4  8/13  62 
8  10/13  77 
20  20/23  87 
SJL 
0.25  1/4.0 
(0.17-0.37)§  (1/2.7-1/5.9)§ 
1  1/11  9 
2  2/7  29 
4  5/12  42  0.046  1/29 
8  6/17  35 
20  11/18  61  (0.032-0.066)§  (1/15-1/31)§ 
40  9/13  69 
* Donor-derived responses showing titers at dilutions greater than 1:4 in recipient sere. 
:~ Probability value estimates were based on the Poisson model, 
§ 95%  confidence intervals shown in parentheses, 
syngeneic donors. The results of these dilution experiments are shown in Table 
II  and  Fig.  2.  The  probability values  and  their  corresponding  limiting  cell 
frequencies were  0.25  and  one  per 4  X  106  for the DBA/1  spleen cells,  and 
0.046 and one per 29 X  106 for SJL spleens, respectively. These differences were G.  M.  SHEARER~  EDNA  MOZES,  AND  MICHAEL  SELA  1013 
statistically significant  (P  =  0.05),  although  less pronounced  than  those  ob- 
tained for  a  secondary  response.  Thus,  expression  of  the  genetic  control  of 
immune responsiveness at the cellular level to an immunogen built on multi- 
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FIG. 2.  Percentage of anti-(Phe,G)-A--L-positive  sera in SJL (symbol O) and DBA/1 
(symbol I)  recipients after irradiation and injection of (Phe, G)-A--L and graded numbers of 
spleen cells from unimmunized syngeneic donors. 
TABLE III 
Cell-to-Cell Infraction for  (T,  G)-Pro--L and  (Phe, G)-A--L  Immune  Responses in  SJL 
and DBA/1 Mice 
Immunogen  Mouse strain  Thymocytes injected  MarrOWinjectedCells  ofFIacti°npositive  of  Percentagepositive 
sera*  sera* 
% 
(T, G)-Pro--L  SJL  7.5  )<  107  0  0/9  0 
0  1.5  X  107  2/24  8 
7.5  X  107  1.5  X  107  16/16  100 
(T, G)-Pro--L  DBA/1  7.5  X  107  0  0/9  0 
0  1.5  )<  107  2/11  18 
7.5  X  107  1.5  X  107  8/11  73 
(Phe, G)-A--L  SJL  1  X  10  ~  0  1/6  16 
0  2  X  107  3/16  19 
1  X  lO  s  2  X  107  9/11  82 
(Phe, G)-A--L  DBA/1  1  X  l0  s  0  0/4  0 
0  2  X  107  4/24  17 
1  X  10  s  2  X  107  14/14  100 
* Donor-derived responses showing titers at dilutions greater than 1:4 in recipient sera. 
chain poly-DL-alanine, i.e.  (Phe,  G)-A--L, is correlated with the relative num- 
bers  of  immune  response  units  detected in  the  spleens  of unimmunized  and 
immunized high and low responder mice. 
Thymus-Bone Marrow Cell Cooperation for (T, G)-Pro--L and  (Phe, G)-A--L 1014  CELL  TYPE  AND  ANTIGEN  STRUCTURE  IN  GENETIC  CONTROL 
Immune  Responses.--In  order  to  determine  whether  the  genetic  controls  of 
immune responsiveness to  (T,  G)-Pro--L or  (Phe,  G)-A--L are expressed in  a 
population  of  thymic helper  cells  or  in  marrow  precursors  of imnmnocytes, 
thymus-marrow  cell  cooperation  experiments  were  performed  for  both  im- 
munogens  in  SJL  and  DBA/1  mice.  As  shown  in  Table  III,  responses 
to  (T,  G)-Pro--L were detected in  a  high proportion of recipients  only when 
both  thymus and  marrow cells  were  injected.  Responses  were  observed in  a 
small fraction (8-18 %) of recipients injected with marrow cells alone. Immune 
TABLE IV 
Percentage of Positive Sera in Irradiated SJL and DBA /1 Recipients 14 Days after Injection of 
(T, G)-Pro--L, l0  s Thymoeytes, and Graded N2tmbers of Marrow Cdls  from Syngeneic Donors 
No,  marrow  Percent- 
cells trans-  Fraction  of  age of  Probability  of positive  Precursor  cell frequency 
Mouse strain  planted  positive sera*  positive  sera per 10 ~' cells{  (X  I0  6).+ 
(X  10 t)  sera* 
SJL 
DBA/1 
% 
0.1  2/13  15 
0.25  5/13  38 
0.5  6/12  50  0.85 
1  8/12  67 
2  7/10  70  (0.54-1.35)§ 
8  7/8  88 
16  16/16  100 
1/1.2 
(1/0.74-1/1.8)§ 
1  3/13  23 
2  8/25  32  0.10  1/10 
4  5/14  36 
8  6/13  46  (0.065-4).15)§  (1/6.7-1/15)§ 
16  8/11  73 
*  Donor-derived responses showing titers at dilutions greater than 1:4 in recipient sera. 
Probability value estimates were based on the Poisson model. 
§ 95% confidence intervals shown in parentheses. 
responses  to  (Phe,  G)-A--L were  also  most  frequent  (82-100%)  in  animals 
injected  with  thymocytes and  marrow cells,  although  a  small  percentage  of 
responses (16  19%) was obtained when only one cell type was injected. These 
low response  frequencies  could have  been  due  to  the  contamination of bone 
marrow or thymus tissue  with  the  complementary cell  type. The  addition of 
thymocytes markedly enhanced the responses of marrow cells in both high and 
low responder  strains  to  (T,  G)-Pro--L and  (Phe,  G)-A--L. The  immune  re- 
sponses of antigens considered to be thymus-independent (by presently accepted 
criteria  in  the  mouse)  should not  be  lower  in  the  absence  of thymocytes or 
thymus-derived  cells  than  when  these  helper  cells  have  been  added  to  the 
marrow-derived  component  of  the  immune  system  (13).  Therefore,  the  re- 
sponses to both synthetic polypeptides appear to be thymus-dependent in the G.  ~{.  SHEARER,  EDNA  MOZES~ AND  MICHAEL  SELA  1015 
sense  that  cell-to-cell interaction between thymocytes and marrow cells was 
demonstrated. 
Frequency  of Anti-(T,  G)-Pro--L  Responses  in SJL  and DBA/1  Recipients 
Injected with Dilutions of Syngeneic Bone Marrow or Thymus Cells.--Irradiated 
SJL  and  DBA/1  mice  were  injected  with  graded  inocula  of  marrow  cells 
(1  X  105 --  1.6 X  107) mixed with 10  s thymocytes from syngeneic donors and 
immunized with 10 vg of (T, G)-Pro--L 24 hr later. The frequency of immune 
responses detected in the  sera of recipients are  shown in Table IV  and Fig. 
3 A, along with the probability values and estimated precursor cell frequencies. 
The data followed the expected Poisson pattern, although some divergence was 
observed at  the  lower cell inocula.  An  eightfold greater  number  of marrow 
precursors was estimated for the SJL high responder than for the DBA/1 low 
responder donors. This finding is similar to the results reported for spleen cells 
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FIG. 3,  Percentage of anti-(T,G)-Pro--L-positive sera in SJL  (symbol ©)  and DBA/1 
(symbol 0)  recipients after irradiation and injection of  (T,G)-Pro--L and:  (A)  10 8 thymo- 
cytes with graded numbers of marrow cells; or (B) 2  X  10 ~ marrow cells with graded numbers 
of thymocytes. All cell combinations were injected into syngeneic hosts. 
using  this  immunogen  (1),  and for spleen and marrow cells using  (Phe,  G)- 
Pro--L (2). 
The limiting dilution results obtained for thymocytes in the  presence of a 
nonlimiting  number  of  2  X  107  syngeneic marrow  cells  are  summarized  in 
Table V and Fig. 3 B. The frequency data obtained conformed to the expected 
Poisson model for both mouse strains. Identical frequencies of helper cells were 
detected (one per 13 X  10  ~ thymocytes) in high and low responder donors, in 
contrast to the spleen and marrow cell dilution studies. This finding is similar 
to the results reported for thymocytes responsive to (Phe, G)-Pro--L (3), and 
indicates that the cellular lesion associated with the Ir-3 genetic defect is not 
expressed in the relative number of thymocytes responding to (T, G)-Pro--L. 
Frequency of Anti-(Phe,  G)-A--L Responses  in SJL and DBA/1  Recipients 
Injected  with  Dilutions  of  Syngeneic  Bone  Marrow  or  Thymus  Cells.--The 
results obtained from transfer of graded inocula of marrow cells along with I0  s 
thymocytes in irradiated syngeneic recipients are shown in Table VI and Fig. 1016  CELL  TYPE  AND  ANTIGEN  STRUCTURE  IN  GENETIC  CONTROL 
4  A. About five times as much immunocompetent activity was detected  per 
106 ceils in the marrow of DBA/1  high responders than in the marrow of SJL 
low responders. This is the reverse of the situation seen for (T, G)-Pro--L (see 
above section),  for which  SJL  are  high  responders  and  DBA/1  are  the  low 
responders. 
Limiting  dilution  experiments using graded numbers  of thymocytes in  the 
presence of 2  X  107 syngeneic marrow cells are summarized in Table VII and 
Fig. 4 B. In contrast to the results of thymus cell dilutions which were obtained 
TABLE V 
Percentage of Positire Sera in Irradiated SJL and DBA /1 Recipients 14 Days after Injection of 
(T,  G)-Pro--L,  2  X  107 Marrow  Cells, and  Graded Numbers  of Thymocytes from 
Syngenelc Donors 
No. thymo-  Percent- 
cytes trans-  Fraction of  age of  Probability of positive  Precursor cell frequency 
Mouse strain  planted  positive sera*  positive  sera per 10  6 eellsl:  (X t0-¢)~t 
(X 10~)  sera* 
SJL 
DBA/1 
% 
2  4/14  29 
5  5/12  42  0.078  1/13 
10  12/17  71 
20  14/19  74  (0.054-0.11)§  (1/9.1-1/19)§ 
40  15/17  88 
2  3/13  23 
5  7/13  54 
10  6/10  60 
20  11/15  73 
40  15/17  88 
60  7/7  100 
0.078  1/13 
(0.0564).11)§  (1/9.1-1/18)§ 
*  Donor-derived responses showing titers at dilutions greater than 1:4 in recipient sera. 
:~ Probability value estimates were based on the Poisson model. 
§ 95% confidence intervals shown in parentheses. 
for  (T,  G)-Pro--L (see  above)  and  for  (Phe,  G)-Pro--L (3),  clear  differences 
were  seen  between  the  response  frequencies  detected  for  DBA/1  and  SJL 
donors. From 6-8 X  107 SJL low responder thymocytes had to be injected in 
order to obtain detectable responses in 2/3 of the recipients. The proportion of 
responses detected as a function of thymus cell number generally followed the 
Poisson pattern, and the estimated helper cell  frequency was one per 6  X  107 
thymocytes. These values are considerably below the frequency of thymocytes 
relevant for generating responses to (T, G)-Pro--L and to (Phe, G)-Pro--L from 
high or low responder donors. Results of limiting dilutions of thymocytes from 
DBA/1 high responder donors to (Phe,  G)-A--L did not conform to the predic- 
tion  of the  Poisson model  (see Table VII and  Fig.  4  B).  The  percentage of 
positive responses detected varied fronl 20% to 90% over a  500-fold range of G. M. SHEARER~  EDNA MOZES, AND MICHAEL SELA  1017 
TABLE  VI 
Percentage of Positive Sera in Irradiated DBA/1 and SJL Recipients 14 Days after Injection 
of (Phe, G)-A--L,  108  Thymocytes, and Graded Numbers  of Marrow  Cells from 
Syngeneic Donors 
No, marrow  Percent- 
Mouse strain  cells trans-  Fraction of  age of  Probability of positive  Precursor cell frequency 
planted  positive sera*  positive  sets per 106 cells~  (X 10-6)~ 
(X 106)  sera* 
DBA/1 
SJL 
% 
0.25  1/6  17 
0.5  6/15  40  0.50  1/2.0 
1  7/15  47 
2  13/21  62  (0.43-0.59)§  (1/1.7-1/2,3)§ 
4  8/12  75 
8  10/11  91 
1  I/ii  9 
2  11/33  33  0.11  1/9.1 
4  11/26  42 
8  6/11  54  (0.087-0.14)§  (1/7.1-1/11)§ 
12  8/15  53 
20  21/24  87 
*  Donor-derived responses showing titers at dilutions greater than 1:4 in recipient sera. 
Probability value estimates were based on the Poisson model. 
§ 95% confidence intervals shown in parentheses. 
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FIG. 4.  Percentage of anti-(Phe,G)-A--L-posltive  sera in SJL  (symbol  O) and DBA/1 
(symbol O) recipients after irradiation and injection of (Phe, G)-A--L and: (A) 108 thymo- 
cytes with graded numbers of marrow cells; or (B) 2 )< 107 marrow cells with graded numbers 
of thymocytes. All cell combinations were injected into syngeneic hosts. 
thymus  cell inocula. Therefore,  the DBA/1  data shown  in Fig. 4  B  has been 
eye fitted to a straight line rather than to a curve describing the Poisson model. 
The  probability value and  the corresponding precursor cell frequency cannot 
be accurately estimated using the Poisson model and the maximum likelihood 
method. Nevertheless, by considering the frequency data obtained from l05 to 
2 X  106 injected thymus cells and from 5  X  106 to 6  X  107 transferred thymo- 1018  CELL  TYPE  AND  ANTIGEN  STRUCTURE  IN  GENETIC  CONTROL 
cytes independently, it is possible to obtain an upper and lower extreme within 
which the frequency of relevant helper cells should be found. This range was 
estimated to be one per 1.5  to 5  X  106 thymocytes, and suggests that DBA/1 
high responder thymocytes are between 12 and 40 times as effective in generat- 
TABLE VII 
Percentage of Positive Sera in Irradiated DBA /1 and SJL Recipients  14 Days after Injection of 
(Phe,  G)-A--L,  2  X  10  7 Marrow  Cells, and  Graded Numbers  of Thymocytes from 
Syngeneic  Donors 
No.  thymo-  Percent- 
Mouse strain  cytes trans-  Fraction of  age of  Probability of positive  Precursor cell 
planted  positive sera*  positive  sera per 106 cells~:  frequency (X 10-6)t 
(X 106)  sera* 
DBA/1 
SJL 
% 
0.12  3/15  20 
0.25  4/14  29 
0.5  5/12  42 
1  12/22  55 
2  12/20  60 
5  9/14  64 
10  23/33  70 
20  8/10  80 
40  8/9  89 
60  9/10  90 
5  4/17  23 
10  2/10  20 
20  8/18  44 
40  7/15  57 
60  8/15  53 
100  21/24  87 
0.20-0.67§  1/1.5-1/5§ 
o.017  1/6o 
(0.012-0.030)][  (I/34-1/88)]r 
*  Donor-derived responses showing titers  at dilutions greater  than 1:4 in recipient sera. 
:~ Probability value estimates were based on the Poisson model. 
§ Since it was not possible to calculate these parameters  for DBA/1  thymocytes  due to 
the lack of adherence to Poisson statistics,  the values shown indicate upper and lower ex- 
tremes. 
I] 95% confidence intervals  shown in parentheses. 
ing a response to (Phe,  G)-A--L as an equal number of thymus cells from SJL 
low responders. 
Since the frequency of SJL thymocytes was found to be only one per 6 X  107 
the marrow cell dilution experiments for this strain may not have included an 
excess of helper cell activity. Therefore, a  dilution experiment of SJL marrow 
cells in the presence of 2 X  108 syngeneic thymocytes was made to verify that 
the marrow dilutions with l0  s low responder thymocytes were correct. Dilutions 
of 2  X  106 and 4  N  106 SJL marrow cells with 2  X  l0  s syngeneic thymocytes 
generated  anti-(Phe,  G)-A--L responses  in 28%  and 40%  of  the  recipients, G.  2¢I. SHEARER~  EDNA  MOZES,  AND  MICHAEL  SELA  1019 
respectively. This is comparable to the results obtained for equal numbers of 
marrow cells transferred with 10  s thymocytes. 
Limiting Dilutions using Allogeneic  Thymus and Marrow Cell Mixtures from 
High  and  Low Responder Donors.--The  dilution experiments described above 
and in preceding reports (1-3)  have involved only syngeneic cell transfers in 
order to avoid possible histoincompatibility difficulties. However, the transfer 
of a cell mixture containing thymocytes and marrow cells from donors differing 
in their immune  response potential to  (Phe,  G)-A--L would serve as  an im- 
portant verification of the syngeneic data,  provided the SJL and DBA/1  cell 
combinations are shown to be functionally immunocompetent. The functional 
interaction of SJL marrow cells and DBA/1 thymocytes in irradiated DBA/1 
hosts  has  been demonstrated for  (Phe,  G)-Pro--L, since the  response to the 
TABLE VIII 
Percentage of Positive Sera in Irradiated DBA/1 Recipients 14 Days after Injection of 
(Phe, G)-A--L and  Thymus and Marrow Cells from  SJL  and~or DBA/1  Donors 
Thymocytes injected  Marrow cells injected  Fraction of positive  Percentage of 
sera*  positive sera* 
% 
7 X 107 DBA/1  4 X 106 DBA/1  6/9  67 
7 N 107 DBA/1  4 X 10  ~ SJL  4/11  36 
7 X 107 DBA/1  1 M 106 SJL  0/5  0 
1  X  107 DBA/1  2  X  107 DBA/1  13/16  81 
1 X 107 SJL  2 X 107 SJL  11/24  46 
* Donor-derived responses showing titers at dilutions greater than  1:4 in recipient sera 
Pro--L specificity, to which SJL is a high responder, was equal to that obtained 
using SJL donors and recipients exclusively (14). Optimal cell-to-cell interaction 
between donors of the SJL and DBA/1 strains has also been demonstrated for 
hen egg white lysozyme (Mozes and Shearer, unpublished data). Thus, results 
obtained  using  marrow-thymus  cell  transfers  from  SJL  low  responder  and 
DBA/1 high responder donors in irradiated DBA/1 recipients should generate 
response  patterns  reflecting  the  genetically  determined  immune  response 
potential of the ceils. 
The results shown in Table VIII, using cell combinations containing an excess 
of DBA/1  thymocytes and limiting numbers of either DBA/1 or SJL marrow 
cells,  indicate that the genetic defect is reflected in the marrow cell numbers, 
since 4 X  10  7 and 1 X  10  7 SJL marrow cells generated lower response frequen- 
cies than an equal number of marrow cells from DBA/1 donors (compare with 
upper portion of Table VI). Furthermore, the fact that these limiting inocula 
of SJL marrow cells in the presence of excess high responder DBA/1  thymo- 
cytes generated response frequencies not higher than those obtained using the 1020  CELL  TYPE  AND  ANTIGEN  STRUCTURE  IN  GENETIC  CONTROL 
same marrow dilutions in the presence of 10  s low responder SJL thymocytes 
indicates  that  the  lower frequency of SJL marrow  cells  detected is  not  an 
artifact due to the reduced frequency of helper cell activity from SJL donors 
(compare with lower portion of Table VI). 
The dilution data of Table VIII using a limiting inoculum of 107 DBA/1 or 
SJL thymocytes with a nonlimiting number of high responder DBA/1 marrow 
cells verifies the syngeneic results that this genetic defect is also reflected in the 
frequency of relevant thymocytes. 
DISCUSSION 
The conversion of low responder mice and guinea pigs to high responders by 
the transfer of lymphoid cells  from high responder donors has demonstrated 
that genetic control of immune response is expressed by at least one population 
of immunocompetent cells  (15-17).  A  number of experiments have been per- 
formed with the objective of establishing whether the functional cell type(s) 
responsible for the low-  or nonresponder state belong to a  population of im- 
munocytes possessing  helper function (i.e. relevant thymus-derived cells  in the 
mouse)  and/or to a  separate category of immunocytes commonly referred to 
as marrow-derived cells,  which are the ancestors of antibody-producing  cells 
(3, 6,  18-20).  Before questioning which cell type is responsible for low respon- 
siveness,  however, it would be helpful to characterize the cellular lesion(s)  by 
asking: "How does the immune system of the low responder animal differ from 
that of the high responder at the cellular level in tissues which normally contain 
all the functional cells  necessary for immunocompetence?" At the  precursor 
cell level,  the differences between high and low responders could reside in: (a) 
the relative numbers of immunogen-activated antigen-sensitive units; (b)  the 
proliferative capacity of a given cell population after immunogenic stimulation; 
(c)  the  number  of receptors  per  cell;  (d)  the  quality  of  cell  receptors  (e.g. 
affinity); and/or (e) some aspects of cell-to-cell  interaction. Results of this and 
other  studies  have  demonstrated  that  the  genetically  controlled  immune 
response  potentials  of  SJL  and  DBA/1  mice  to  (T,  G)-Pro--L  (1),  to  the 
Pro--L- and (Phe, G)-specific responses of (Phe, G)-Pro--L (2),  and to (Phe, 
G)-A--L (see Tables I  and II; Figs. 1 and 2) are all reflected in the numbers of 
relevant  immunocompetent  precursors  stimulated  in  the  spleens  of  either 
immunized or  unimmunized donors.  These  detected differences in  precursor 
frequency could represent the real defect(s), and thereby indicate actual total 
cell numbers, or they could be the result of any of the other above mentioned 
possibilities, with the exception of proliferation of thymocytes responsive to 
(Phe,  G)-Pro--L, which was shown not to be defective in the low responders 
(3). The possibility of a defect existing in the proliferative capacity of thymus- 
derived cells after immunization with (Phe, G)-A--L has not yet been examined. 
However, it is unlikely to be the only defect, since  the low responsiveness of 
SJL mice to (Phe, G)-A--L can be attributed to both thymus and marrow cell G.  M.  SHEARER~  EDNA  MOZES,  AND  MICHAEL  SELA  1021 
populations  (Tables VI-VIII; Fig. 4).  Irrespective of whether the precursor 
cell  frequency differences observed between high and low responder  animals 
represent the sole phenotypic abberation or whether they are only the manifes- 
tation of a more complex phenomenon, the observation that the spleens of the 
high responder  strains exhibit from 8-  to 24-fold  greater  immunocompetent 
activity has provided a useful approach for comparing these genetically deter- 
mined lesions in thymus and marrow cell populations (3, 14). 
The results obtained using cell dilutions for the (Phe, G)-A--L  immunogen, 
which is known to lead only to an anti-(Phe, G) response, indicated differences 
of seven-  and seventeenfold, respectively,  for  spleens  of  unimmunized  and 
immunized high and low responder donors, (Tables I  and II; Figs. 1 and 2).  It 
is noteworthy that  a  significant increase in the frequency of precursors was 
obtained as a result of preimmunizing the DBA/1 high responders, whereas no 
change was detected in  precursor  frequency by  preimmunizing the  SJL low 
responder strain. Similarly, preimmunization had no effect on the DBA/1 low 
responders to (T, G)-Pro--L (1) which leads only to anti-Pro--L response (4), 
and on the SJL low responders to the (Phe, G) immunopotent region of (Phe, 
G)-Pro--L (2). The only case in which an increase in relevant splenic precursor 
cell frequency was obtained in a low responsive situation was for the DBA/1 
response  to  the  Pro--L  portion  of  (Phe,  G)-Pro--L.  In this  experiment  the 
enhancement of the low anti-Pro--L response appeared to be due to the pres- 
ence of a  second (Phe,  G)  immunopotent region, to which DBA/1  mice are 
high responders. The presence of a second immunopotent area, however, does 
not necessarily ensure an increase in low responder spleen cell frequency as a 
result of immunization, since the low (Phe, G) secondary response potential of 
SJL mice was not enhanced by primary immunization with (Phe,  G)-Pro--L 
(2). Possibly, a helper role may be envisaged for the memory of low responders 
controlled by Ir-3 gene but not by It-1 gene. 
Similar to the results reported for (Phe, G)-Pro--L (3),  as seen in Table III, 
cell-to-cell  interaction between thymocytes and marrow cells is required for the 
generation of immune responses specific for (T, G)-Pro--L and for (Phe, G)-A'L 
in irradiated recipients immunized with these immunogens in complete Freund's 
adjuvant. Although immune responses were detected in a small percentage of 
recipients injected with thymocytes or marrow cells  alone, these percentages 
were much lower than those observed using the cell mixtures, and may indicate 
contamination of the bone marrow and thymus, respectively, with an occasional 
helper cell or antibody-forming cell precursor. 
The  results  obtained  for  (T,  G)-Pro--L  using  limiting numbers  of  either 
marrow cells  or thymocytes in the presence  of a  nonlimiting number of the 
complementary cell type are similar to the results reported for (Phe, G)-Pro--L 
(3).  An eightfold lower frequency of relevant precursors was observed in the 
marrow of SJL low responders than in the marrow of high responder DBA/1 
donors (Table IV, Fig. 3 A). In contrast, no differences were detected in the 1022  CELL  TYPE  AND  ANTIGEN  STRUCTURE  IN  GENETIC  CONTROL 
frequencies of thymic helper cells  required to generate  (T,  G)-Pro--L-specific 
responses in the high and low responder strains (Table V, Fig. 3 B). These cell 
frequency differences detected only in  spleen  (1)  and bone marrow cell sus- 
pensions might  reflect actual  differences in  antibody-forming cell precursors, 
but in view of recent results obtained with poly-alanine-poly-uridine (polyA- 
polyU)  and  peritoneal  exudate cells  (14,  21),  they probably reflect  an Ir-J 
genetic defect involving celbto-ceU interaction. 
The  results  obtained  with  the  bone  marrow-  and  thymus  cell-limiting 
dilutions  for  the  (Phe,  G)-A--L  immunogen  (controlled  by  Ir-i  gene)  are 
different from those seen for (T,  G)-Pro--L (controlled by Ir-3 gene),  or for 
the Pro--L  specifc (If-J)  and  (Phe,  G)-specific (Ir-1)  responses of  (Phe,  G) 
Pro--L  (3).  In  contrast  to  the  results  obtained  with  these  immunopotent 
specifidties characteristic for the polyproline-based immunogens, we have used 
in these studies,  dilution experiments for the  low  (Phe,  G)-specific response 
on  (Phe,  G)-A--L in SJL  mice indicated  a  clear  defect in  the  population of 
thymic helper cells  (Table VII, Fig. 4 B), as well as in the marrow population 
(Table VI, Fig. 4 A). Dilutions of SJL thymocytes conformed to the predictions 
of the Poisson model, whereas those from DBA/1 donors did not (see Fig. 4 B). 
This non-Poisson curve suggests not  only that  there  are  more  thymus  cells 
relevant for  generating  (Phe,  G)-A--L responses  in  the  DBA/1  than  in  the 
SJL strain (compare the 5 X  106 to 6 X  107 inocula of Table VII), but that the 
helper cell activity of DBA/1  thymocytes is  more efficient than  that  of the 
SJL  low  responder  strain.  Strain-dependent  variations  involving  lack  of  or 
adherence to a Poisson pattern generated by dilutions of marrow cells reactive 
with  sheep  erythrocytes have  been  reported  (22,  23).  The meaning  of such 
differences is not fully understood, although for ewthrocyte immunogens they 
appear to be associated with steps in cell differentiation which can be induced 
by immunization (24). In the present study the frequency of detected immune 
responses was  not  a  function of DBA/1  thymocyte number  and  this  ,night 
suggest  some  degree of thymus  independence,  or involvement of a  humoral 
factor which might not be related directly to thymocyte number. 
The fnding that thymus cell suspensions from SJL donors contain only one 
detectable helper cell per  6  X  107 thymocytes could indicate  that  the  data 
obtained for low responder marrow cell dilutions represent an  artifact,  since 
10  s syngeneic thymus cells would not contain a real excess of helper cell activity. 
However, the observation that the same frequency of responses was obtained 
with  limiting dilutions of SJL  marrow in  the  presence of 10  s SJL,  2  X  10  s 
SJL, or 10  s DBA/1 thymocytes verifies that the lower precursor cell frequency 
detected in  SJL bone marrow is  not  the  result  of an  insufficient number of 
thymocytes  (compare  Tables  VI  and  VII  with  Table  VIII  for  equivalent 
inocula of limiting marrow cells mixed with  10  s SJL or DBA/1  thymocytes). 
The  use  of limiting  dilutions  for studying  the  cellular  aspects  of genetic 
control of immune responsiveness offers the advantage that transfers of syn- G.  M.  SHEARER,  EDNA  MOZES,  AND  MICHAEL  SELA  1023 
geneic cell mixtures can be used, and thus avoids possible cell-to-cell or donor- 
host histocompatibility problems which could complicate interpretation of the 
results  (18). In other words, when transfers of cell mixtures from donor mice 
differing in their H-2 type as well as their immune response potential are used, 
one has  to be certain that  any low response observed is  due to the genetic 
lesion, and is not the result of suboptimal  cell-to-cell interaction due to/t-2 
differences. 
Thymus-marrow cell cooperation across  an //-2  barrier and the  ability of 
these cell mixtures to generate immune responses in irradiated  allogeneic or 
F1 hosts  appears to be  a  function of the  particular mouse strains used  (25). 
Published  (14)  and unpublished results from this laboratory, using  (Phe, G)- 
Pro--L  and  lysozyme as  immunogens,  have  indicated  that  combinations  of 
thymocytes  and  marrow  cells  from  SJL  and  DBA/1  donors  in  irradiated 
recipients of either parental strain generated responses identical to those from 
syngeneic  combinations  of  equal  cell  numbers.  The  results  summarized  in 
Table VIII, using allogeneic cell mixtures, in which the donor of only one cell 
type was a low responder, are similar to the data obtained using syngeneic cell 
mixtures. This indicates that the low response potential of SJL mice to (Phe, G)- 
A--L is reflected in the frequencies of both thymus and marrow cell popula- 
tions relevant for responsiveness to this synthetic polypeptide, and verifies the 
results obtained using cell combinations from syngeneic donors. 
From these investigations a series of patterns are beginning to emerge con- 
cerning  the  interrelationships  among  the  molecular,  cellular,  and  genetic 
aspects of immunity  (Table IX). The It-1  genetic lesion, which is linked to 
//-2, cannot be corrected by polyA-polyU treatment or by syngeneic peritoneal 
exudate cells, although the low responses controlled by both genes are enhanced 
by complexing these immunogens electrostatically to methylated bovine serum 
albumin (14). The Ir-1  defect appears to involve immunological memory and 
may be related to carrier function, since it is not subject to amplification in the 
low responder strain by the presence of a second determinant on the immunogen 
to which that strain responds normally. The non-//-2-1inked Ir-3 genetic defect 
appears to be a less severe lesion than Ir-1 in the sense that the nonimmunogen- 
specific treatments of polyA-polyU and peritoneal cells corrected the response 
of the low responder DBA/1 mice to a specific immunogen (14)  and that the 
ability to elicit an enhanced secondary response is present, provided that the 
immunogen  contains  a  second  immunopotent  determinant  to  which  this 
strain responds normally (2). The enhancement of the Pro--L-specific response 
in DBA/1  mice to the high responder level by polyA-polyU or by increasing 
the number of syngeneic peritoneal cells suggests that the Ir-3 lesion may not 
involve a  defect in  the  actual  number  of Pro--L-specific immunocompetent 
precursors in spleen and bone marrow, since it is unlikely that these treatments 
would  be  immunogen-specific. It  is  possible  that  the  It-3  defect involves  a 
step in cell-to-cell interaction which would be seen in the relative numbers of 1024  CELL  TYPE  AND  ANTIGEN  STRUCTURE  IN  GENETIC  CONTROL 
splenic antigen-sensitive units  and  of marrow  precursors  of antibody-forming 
cells stimulated (14). 
The It-1 defect is reflected in the limiting cell populations present in spleen 
and bone marrow for both the Pro--L and A--L series of branched chain poly- 
peptides, but is detected in relevant thymocyte numbers only when the (Phe, G) 
immunopotent  determinant  is carried on  a  poly-DL-alanine side chain  (Table 
IX). This latter observation suggests that different populations of thymocytes 
TABLE IX 
Emerging Patterns of Genetic  Control  of Immune Responsiveness in SJL and DBA/1 Mice to 
Synthetic Polypeptides Built on Multichain Poly-L-Proline or on Multichain Poly-DL-Alanine 
Immunogen studied:  (T, G)-Pro--L  (Phe, G)-Pro -L  (Phe, G)-A--L 
Response specific for:  Pro--L  Pro--L  (Phe, G)  (Phe, G) 
Genetic characterization of response* 
Low responder strain 
High responder strain 
Linked to H-2 
Designation of gene 
PolyA-polyU treatment 
Syngeneic peritoneal cells 
Methylated bovine serum 
albumin 
DBA/1  DBA/1  SJL  SJL 
SJL  SJL  DBA/I  DBA/I 
No  No  Yes  Yes 
Jr-3  lr-3  Ir-1  Ir-1 
Low responders enhanced  by~ 
Yes  Yes  No  No 
Yes  Yes  No  No 
Yes  Yes  Yes  Yes 
Ratio of precursor cells in high to Iow responder donors§ 
Spleen,  secondary  re-  24:1  7:1  12:1  18:1 
sponse 
Spleen, primary response  4:1  11 : 1  3 : 1  7 : I 
Marrow,  primary  re-  8:1  5:1  5:1  5:1 
sponse (excess thymus) 
Thymus,  primary  re-  1:1  1:1  1:1  (12-40) :1 
sponse (excess marrow) 
* See references 5, 6, and 9. 
:~ See references 14 and 21. 
§ See references 1-3 and this study. 
respond  to  the  Pro--L  and  A--L polypeptides, and  that  only the  population 
stimulated by A--L may  be  defective in SJL mice. The  observation that  the 
genetic  defect  to  (Phe,  G)  in  this  strain  is  reflected  only  in  the  number  of 
marrow precursors when these peptides are attached to poly-L-proline whereas 
the  defect  is  reflected in  the  number  of both  marrow  and  thymus  immuno- 
competent  cells  when  (Phe,  G)  is  attached  to  poly-DL-alanine, stresses  the 
importance of the chemical structure of the entire immunogenic macromolecule 
in  the  expression of the genetic defects for  a  given specificity at  the cellular 
level. G.  M.  SHEARER,  EDNA MOZES, AND  MICHAEL SELA  1025 
SUMMARY 
Genetic  regulation  of  immunological  responsiveness  was  studied  at  the 
cellular level by comparing the  limiting dilutions of immunocompetent cells 
from spleen, thymus, and bone marrow of high and low responders as a func- 
tion of the poly-L-prolyl and poly-DL-alanyl side chains of two synthetic poly- 
peptide  immunogens. The  spleens  of immunized and unimmunized high re- 
sponder DBA/1 mice were found to contain respectively, i8- and 7-fold more 
limiting precursor cells specific for (Phe, G)-A--L than the spleens of SJL low 
responder donors. These results, using a synthetic polypeptide built on multi- 
chain poly-DL-alanine,  confirm the findings reported for polypeptides built on 
multichain poly-L-proline  (1,  2),  that  there  is  a  direct  correlation  between 
immune  response  potential  and  the  relative  number  of  immunocompetent 
precursors stimulated. 
Cell  cooperation between thymocytes and bone  marrow cells  was  demon- 
strated  for  both  (T,  G)-Pro--L  and  (Phe,  G)-A--L.  Limiting  dilutions  of 
thymus and bone  marrow cells  in the presence  of  an  excess  amount of the 
complementary  cell  type  indicated  an  eightfold lower  number  of  detected 
(T,  G)-Pro--L-specific  precursors  in  DBA/1  (low  responder)  marrow when 
compared with SJL (high responder) marrow. No differences were observed in 
the frequency of relevant high and low responder thymocytes for the (T,  G)- 
Pro--L immunogen. These results are similar to those reported for the (Phe,  G)- 
Pro--L (3). In contrast to the cellular studies reported for the Pro--L series  of 
immunogens,  the  marrow  and  thymus  cell  dilution  experiments  for  (Phe, 
G)-A--L  revealed genetically associated differences in both  the marrow  and 
thymus populations of immunocytes from high  (DBA/1)  and low (SJL)  re- 
sponders. In addition to a fivefold difference in limiting marrow cell precursors 
(similar to that seen in the Pro--L studies), a striking difference was observed 
between the helper cell activity of high responder DBA/1  and low responder 
SJL thymocytes. This difference was  indicated by the  observation  that low 
responder thymocyte dilutions followed the predictions  of the Poisson model, 
whereas dilutions of high responder thymocytes did not conform  to Poisson 
statistics.  Transfers  of  allogeneic  thymus  and  marrow  cell  mixtures  from 
DBA/1 and SJL donors confirmed the syngeneic dilution studies showing that 
the genetic defect of immune responsiveness  to  (Phe, G)-A--L is expressed at 
both the thymus and marrow immunocompetent cell level. 
The parameters  presently known for genetic control  of immune responses 
specific for (Phe, G) (Ir-1 gene) and for Pro--L (Ir-3 gene) have been compared. 
The Ir-1 and Ir-3 genes are not only distinct by genetic linkage tests (to H-2) 
(5, 6, 9), but they are also seen to be different by cellular studies. Furthermore, 
expression of low responsiveness within a given cell population was shown to 
depend on the chemical structure of the whole immunogenic macromolecule. 
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